麻疹消除目标：印度可行吗？

Measles elimination goal: is it feasible for India?

机构信息

Senior Resident, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India.

出版信息

Indian J Public Health. 2010 Oct-Dec;54(4):190-3. doi: 10.4103/0019-557X.77258.

DOI:10.4103/0019-557X.77258

PMID:21372365

Abstract

OBJECTIVE

To assess whether measles elimination goal would be feasible for India or not.

METHODOLOGY

Secondary review of data from WHO Regional Consultative Meet on Measles and Workshop on Rubella. Discussion with stakeholders such as UNICEF experts, PATH, and Government officials.

RESULTS

The National Technical Advisory Group of India (NTAGI) has chalked out two broad strategies depending on the routine measles coverage of first dose (MCV1). In 18 states with sustained MCV1 coverage ≥80%, a second routine dose of measles would be given, whereas those states with <80% coverage, supplementary immunization will be introduced in a phased manner. There are many challenges at this juncture-unfinished agenda polio eradication, lack of VPD surveillance system, financial and manpower constraints. However, solutions are possible.

CONCLUSION

Before setting an elimination goal in India, a thorough understanding of the regional situation is required. India should opt for the Measles Mortality Reduction before proceeding to the Elimination Goal by 2020.

摘要

目的

评估印度是否能够实现消除麻疹的目标。

方法

对世界卫生组织区域麻疹协商会议和风疹研讨会的数据进行二次审查。与利益相关者（如联合国儿童基金会专家、PATH 和政府官员）进行讨论。

结果

印度国家技术咨询小组（NTAGI）根据第一剂常规麻疹疫苗接种率（MCV1）制定了两项广泛的策略。在 18 个 MCV1 覆盖率持续≥80%的州，将接种第二剂常规麻疹疫苗，而那些覆盖率<80%的州将分阶段引入补充免疫。目前存在许多挑战，包括未完成的脊髓灰质炎根除议程、缺乏疫苗相关疾病监测系统、资金和人力限制。但是，解决方案是可行的。